Biggest News Aggregation in the World
📰 Olid News

Page 22 - Olid News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Olid. Real-time updates on events, politics, business and more.

New data presented at AACR Annual Meeting demonstrates significantly enhanced anti-solid tumor effects of T cells co-expressing an optimal affinity TCR targeting NY-ESO-1 and a PD1-41BB co-stimulatory switch receptor (MDG1015)

Martinsried/Munich, April 18, 2023, Medigene AG , an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today presents preclinical... | April 18, 2023
United States New York Pamela Keck Hongsheng Sciences Prime Standard Polyfunctional Strength Index

Alpine 4 Holdings, Inc. Subsidiaries, RCA Commercial and Elecjet, Enter Material Transfer Agreements with OEMs to Begin Testing of its Latest AX-03 Class of Solid-State Batteries

PHOENIX, AZ / ACCESSWIRE / April 18, 2023 / Alpine 4 Holdings, Inc. (NASDAQ:ALPP), a leading operator and owner of small market businesses, announced that its subsidiaries, RCA Commercial and Elecjet,
United States Samuel Gong Kent Wilson Holdings Inc View Manufacturing Or Construction Services Energy Storage Systems Powerwalls

Context Therapeutics Inc.: Significant Unmet Need In Solid Tumors Reported, And How Context Therapeutics Plans To Make A Difference

PHILADELPHIA, PA / ACCESSWIRE / April 18, 2023 / Context Therapeutics Inc. (NASDAQ:CNTX) is a biopharmaceutical company committed to advancing medicines for solid tumors by harnessing novel and innovative
United States Laine Yonker National Cancer Institute American Association For Cancer Research Context Therapeutics Inc Therapeutics Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting

Allogeneic iNKTs, agenT-797, administered alone or in combination with anti-PD-1 therapy, shows activity in patients with refractory solid tumor cancers.In a patient with metastatic gastric cancer who... | April 18, 2023
United States New York Memorial Sloan Kettering Cancer Center Jennifer Buell Benedito Carneiro Zack Armen

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science